001438796 000__ 05057cam\a2200565\i\4500
001438796 001__ 1438796
001438796 003__ OCoLC
001438796 005__ 20230309004354.0
001438796 006__ m\\\\\o\\d\\\\\\\\
001438796 007__ cr\un\nnnunnun
001438796 008__ 210810s2021\\\\sz\a\\\\o\\\\\000\0\eng\d
001438796 019__ $$a1263872224
001438796 020__ $$a9783030763206$$q(electronic bk.)
001438796 020__ $$a303076320X$$q(electronic bk.)
001438796 020__ $$z9783030763190
001438796 020__ $$z3030763196
001438796 0247_ $$a10.1007/978-3-030-76320-6$$2doi
001438796 035__ $$aSP(OCoLC)1263284557
001438796 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCO$$dOCLCF$$dUKAHL$$dN$T$$dOCLCQ$$dCOM$$dOCLCQ$$dOCLCO$$dOCLCQ
001438796 049__ $$aISEA
001438796 050_4 $$aQR177$$b.B56 2021
001438796 08204 $$a616.9/041$$223
001438796 24500 $$aBiochemistry of drug resistance /$$cSarfraz Ahmed, Suvash Chandra Ojha, Muhammad Najam-ul-Haq, Muhammad Younus, Muhammad Zaffar Hashmi, editors.
001438796 264_1 $$aCham :$$bSpringer,$$c[2021]
001438796 264_4 $$c©2021
001438796 300__ $$a1 online resource :$$billustrations (chiefly color)
001438796 336__ $$atext$$btxt$$2rdacontent
001438796 337__ $$acomputer$$bc$$2rdamedia
001438796 338__ $$aonline resource$$bcr$$2rdacarrier
001438796 5050_ $$a1. Introduction to Drugs, Drug Targets and Drug Resistance -- 2. Drugs Resistance in Bacterial Diseases -- 3. Drugs Resistance Against Viral Diseases -- 4. Drug Resistance in Protozoal Infections -- 5. Antifungal Drugs: Mechanism of Action and Resistance -- 6. Drug Resistance in Ear, Nose, and Throat Infections -- 7. Drug Resistance in Skin Diseases -- 8. Drugs Resistance in Lungs Diseases -- 9. Neurological Disorders: Biochemistry of Drug Resistance and Future Challenges -- 10. Drug Resistance in Kidney Diseases -- 11. Drugs resistance in Heart Diseases -- 12. Drugs Resistance in Liver Disease -- 13. Drug Resistance in Cancer -- 14. Drugs Resistance and Treatment Failure in HIV and / or AIDS -- 15. Drug Resistance in Reproductive Diseases -- 16. Drug Resistance in Diabetes -- 17. Drug Resistance in Rheumatological Diseases -- 18. Pherotypes in Streptococcus pneumoniae and Role of CSP-1 and CSP-2 in Antibiotic Susceptibility and Resistance; Towards Development of Live Attenuated Vaccine Candidates in Inducing Netosis Based Acquired Immune Response -- 19. Hypoxia, Obesity and Drug Resistance; Towards Sustainable Development Goals and Globalization -- 20. Genetic and Molecular Mechanisms of Multidrug-resistance in Uropathogens and Novel Therapeutic Combat -- 21. Drugs Resistance Management.
001438796 506__ $$aAccess limited to authorized users.
001438796 520__ $$aThis book provides a comprehensive discussion on the current information and evidence on the latest developments in the field of drugs resistance. Drug resistance is the reduction in effectiveness of a medication such as an antimicrobial or an antineoplastic in treating a disease or condition. This leads to negative outcomes at great risk of public health; therefore, increasing efforts are dedicated to the development of a new generation of medications that will help deal with this phenomenon. Decades of technological innovations in drug design have demonstrated the potential of resistance. Enormous information on various aspects of antibiotics resistance is available. However, literature on drug resistance specifically related to infectious and non-infectious diseases is rarely presented, particularly those focusing on the mechanisms, biochemistry, kinetics, dynamics, and management of drug resistance. Therefore, there is an immense need for a systematic compilation on the available information about this issue. All the chapters are logically selected and arranged to provide state-of-the-art information about all aspects of drugs resistance. After an introductory chapter, four chapters are dedicated to infectious microbial diseases, whereas two other chapters are complimenting this theme and focusing on drugs resistance in ear, nose and throat, and skin diseases. The recent advances in the understanding of drugs resistance in lung, neurological, kidney, heart, and liver diseases are also covered. Biochemistry of drugs resistance in cancer, HIV, ocular, reproductive, and diabetes diseases is also discussed. Finally, a chapter dedicated to the management of drug resistance has been included.
001438796 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 24, 2021).
001438796 650_0 $$aDrug resistance.
001438796 650_0 $$aPharmaceutical chemistry.
001438796 650_6 $$aRésistance aux médicaments.
001438796 650_6 $$aChimie pharmaceutique.
001438796 655_0 $$aElectronic books.
001438796 7001_ $$aAhmed, Sarfraz,$$eeditor.
001438796 7001_ $$aChandra Ojha, Suvash,$$eeditor.
001438796 7001_ $$aNajam-ul-Haq, Muhammad,$$eeditor.
001438796 7001_ $$aYounus, Muhammad,$$eeditor.
001438796 7001_ $$aHashmi, Muhammad Zaffar,$$eeditor.
001438796 77608 $$iPrint version:$$z3030763196$$z9783030763190$$w(OCoLC)1246351965
001438796 852__ $$bebk
001438796 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-76320-6$$zOnline Access$$91397441.1
001438796 909CO $$ooai:library.usi.edu:1438796$$pGLOBAL_SET
001438796 980__ $$aBIB
001438796 980__ $$aEBOOK
001438796 982__ $$aEbook
001438796 983__ $$aOnline
001438796 994__ $$a92$$bISE